0.00Open1.04Pre Close0 Volume126 Open Interest12.00Strike Price0.00Turnover71.22%IV0.23%PremiumNov 15, 2024Expiry Date1.01Intrinsic Value100Multiplier9DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.7870Delta0.1988Gamma10.62Leverage Ratio-0.0248Theta0.0022Rho8.36Eff Leverage0.0060Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet